XML 55 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Components of income tax expense (benefit)
Components of income tax expense (benefit) (in thousands) consist of the following:

 
For the Years Ended December 31,
 
2018
 
2017
 
2016
Current
 
 
 
 
 
Federal
$
458

 
$
368

 
$

State and local
9

 
266

 

Foreign
251

 

 

Total current tax expense
718

 
634

 

Deferred
 
 
 
 
 
Federal
(14,820
)
 
3,202

 
(9,708
)
State and local
(2,252
)
 
(3,102
)
 
(1,138
)
Foreign
(49
)
 

 

Total deferred tax expense
(17,121
)
 
100

 
(10,846
)
Change in valuation allowance
16,443

 
(7,371
)
 
91

Total tax expense (benefit)
$
40

 
$
(6,637
)
 
$
(10,755
)
Schedule of reconciliation of the U.S. statutory tax rate to our effective tax rate
A reconciliation of the U.S. statutory tax rate to our effective tax rate is presented below:

 
For the Years Ended December 31,
 
2018
 
2017
 
2016
U.S. statutory tax rate
21.0
 %
 
35.0
 %
 
35.0
 %
U.S. state income taxes, net of U.S. federal tax benefit
3.6
 %
 
3.3
 %
 
4.0
 %
Foreign earnings at other than U.S. rates
(0.2
)%
 
 %
 
 %
Change in valuation allowance
(30.4
)%
 
(34.0
)%
 
(0.1
)%
Change in valuation allowance, tax reform
 %
 
43.7
 %
 
 %
Impact of tax reform
 %
 
(36.0
)%
 
 %
Goodwill impairment
 %
 
 %
 
(18.7
)%
Gain on contribution
 %
 
 %
 
(5.0
)%
Non-controlling interest
(0.7
)%
 
(4.6
)%
 
(11.0
)%
Excess tax benefits on stock-based compensation
3.9
 %
 
3.1
 %
 
0.1
 %
Federal and state R&D tax credits
4.5
 %
 
 %
 
 %
Change in uncertain tax positions
(1.1
)%
 
 %
 
 %
Other, net
(0.7
)%
 
(1.8
)%
 
0.2
 %
Effective rate
(0.1
)%
 
8.7
 %
 
4.5
 %
Schedule of deferred tax assets and liabilities
Significant components of the Company’s deferred tax assets and liabilities (in thousands) were as follows:

  
As of December 31,
  
2018
 
2017
Deferred Tax Assets
 
 
 
Start-up and organizational costs
$
160

 
$
185

Internally developed software costs
3,283

 
3,974

Net operating loss carryforwards
76,019

 
51,197

Federal and state R&D tax credits
1,828

 

Other
861

 
(69
)
Subtotal
82,151

 
55,287

Valuation allowance
(37,037
)
 
(53,201
)
Total deferred tax assets
45,114

 
2,086

 
 
 
 
Deferred Tax Liabilities
 
 
 
Equity-method investment
43,492

 
4,523

Intangible assets
26,710

 

Total deferred tax liabilities
70,202

 
4,523

Net deferred tax assets (liabilities)
$
(25,088
)
 
$
(2,437
)
Changes in valuation allowance
Changes in our valuation allowance (in thousands) were as follows:

 
For the Years Ended December 31,
 
2018
 
2017
 
2016
Balance at beginning-of-year
$
53,201

 
$
26,376

 
$
19,974

Charged to costs and expenses
16,443

 
(7,371
)
 
91

Charged to other accounts (1)
(32,607
)
 
34,196

 
6,311

Balance at end-of-year
$
37,037

 
$
53,201

 
$
26,376


(1) 
Amounts charged to other accounts includes a decrease of $32.6 million, increase of $34.2 million and increase of $6.3 million charged to additional paid-in-capital for the years ended December 31, 2018, 2017 and 2016, respectively.
Changes in unrecognized tax benefits
Changes in our unrecognized tax benefits (in thousands) were as follows:

 
For the Years Ended December 31,
 
2018
 
2017
 
2016
Balance at beginning-of-year
$
762

 
$

 
$

Gross increases - tax positions in prior period
934

 
1,108

 

Gross decreases - tax positions in prior period
(762
)
 

 

Gross increases - tax positions in current period

 
74

 

Change in tax rate

 
(420
)
 

Balance at end-of-year
$
934

 
$
762

 
$